Previous Close | 109.71 |
Open | 110.22 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 2900 |
Day's Range | 109.00 - 112.70 |
52 Week Range | 81.60 - 149.57 |
Volume | |
Avg. Volume | 81,874 |
Net Assets | 185.66M |
NAV | 112.41 |
PE Ratio (TTM) | N/A |
Yield | 0.02% |
YTD Daily Total Return | -21.44% |
Beta (5Y Monthly) | 2.36 |
Expense Ratio (net) | 0.97% |
Inception Date | 2011-06-15 |
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2022) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and investment update to the market and its stakeholders. BPK is currently under way to develop ROR1 CAR-T for a chronic leukemia treatment and Innovative CAR-T which can treat lung and ovarian cancer. All new CAR-T products under development are a bi-specific (dual antibody binding) ...